Ramadan, M.S.; Boccia, F.; Moretto, S.M.; De Gregorio, F.; Gagliardi, M.; Iossa, D.; Durante-Mangoni, E.; Zampino, R.
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. J. Clin. Med. 2022, 11, 5781.
https://doi.org/10.3390/jcm11195781
AMA Style
Ramadan MS, Boccia F, Moretto SM, De Gregorio F, Gagliardi M, Iossa D, Durante-Mangoni E, Zampino R.
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Journal of Clinical Medicine. 2022; 11(19):5781.
https://doi.org/10.3390/jcm11195781
Chicago/Turabian Style
Ramadan, Mohammad Said, Filomena Boccia, Simona Maria Moretto, Fabrizio De Gregorio, Massimo Gagliardi, Domenico Iossa, Emanuele Durante-Mangoni, and Rosa Zampino.
2022. "Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals" Journal of Clinical Medicine 11, no. 19: 5781.
https://doi.org/10.3390/jcm11195781
APA Style
Ramadan, M. S., Boccia, F., Moretto, S. M., De Gregorio, F., Gagliardi, M., Iossa, D., Durante-Mangoni, E., & Zampino, R.
(2022). Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Journal of Clinical Medicine, 11(19), 5781.
https://doi.org/10.3390/jcm11195781